Transcriptomics

Dataset Information

0

Breast cancer cell lines treated with mebedazole (an FDA-approved anti-parasitic) under 20% or 1% oxygen conditions.


ABSTRACT: The main purpose of this project is to identify gene expression changes between treated breast cancer cells (w/ MBZ) vs. non-treated cells (w/o MBZ) under normal (20% O2) or hypoxic (1% O2) conditions. Preliminary analysis using iclue revealed that MBZ might behave similarly to HIF inhbitors so we hypothesize that MBZ might repress HIF-response under hypoxia. We have submitted three different cell lines: SUM159 (SM), MDA-MB-231 (MDA) and MCF7; MBZ treatment: 0uM of MBZ (0M or 0); 1uM MBZ (1M or 1); Oxygen conditions: 1% O2 - hypoxia (H); 20% O2 - normoxia (N).

ORGANISM(S): Homo sapiens

PROVIDER: GSE222702 | GEO | 2023/01/23

REPOSITORIES: GEO

Similar Datasets

2022-02-28 | GSE190845 | GEO
2021-03-02 | GSE167956 | GEO
2022-02-17 | PXD024373 | Pride
2010-06-24 | E-GEOD-17524 | biostudies-arrayexpress
2014-02-10 | E-MTAB-1994 | biostudies-arrayexpress
2014-09-30 | E-GEOD-61842 | biostudies-arrayexpress
2010-06-21 | E-GEOD-18494 | biostudies-arrayexpress
2014-09-30 | GSE61842 | GEO
2012-10-31 | GSE39681 | GEO
2009-10-09 | GSE18494 | GEO